Covigilant Research, LLC Clinical Trials Site Management Organization

Covigilant Research, LLC

Committed To Working Together

Enzychem Lifesciences Announces Database Lock for Phase 2 Study of EC-18 … – TylerPaper.com,

“There is a significant unmet medical need in CRIOM, and we look forward to advancing EC-18, a first-in-class oral therapy, to the next clinical stage …, “There is a significant unmet medical need in CRIOM, and we look forward to advancing EC-18, a first-in-class oral therapy, to the next clinical stage …, Read More

Scroll to Top